According to Colao et al., pasireotide-induced hyperglycemia in patients with CD should be treated first with metformin alone and then in combination with a DPP-4 inhibitor, with a switch to a GLP-1 RA and initiation of insulin, as needed (61). This evidence concerns the gene DPP4 and Hyperglycemia.